Your browser doesn't support javascript.
loading
Relative Bioavailability and Food Effect Evaluation for 2 Tablet Formulations of Asciminib in a 2-Arm, Crossover, Randomized, Open-Label Study in Healthy Volunteers.
Menssen, Hans D; Quinlan, Michelle; Kemp, Charisse; Tian, Xianbin.
Affiliation
  • Menssen HD; Novartis Pharma AG, Basel, Switzerland.
  • Quinlan M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Kemp C; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Tian X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Clin Pharmacol Drug Dev ; 8(3): 385-394, 2019 04.
Article in En | MEDLINE | ID: mdl-30059193
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Fusion Proteins, bcr-abl / Niacinamide / Food-Drug Interactions Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Drug Dev Year: 2019 Document type: Article Affiliation country: Switzerland Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Fusion Proteins, bcr-abl / Niacinamide / Food-Drug Interactions Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Drug Dev Year: 2019 Document type: Article Affiliation country: Switzerland Country of publication: United States